• -
66 Results
This photo depicts many stem cells.
Can We Do That Here? An Analysis of U.S. Federal and State Policies Guiding Human Embryo and Embryoid Research
Scientists and members of the public exploring the controversial area of U.S. human embryo and embryoid research will find a complex and sometimes bewildering assortment of federal and state laws. The authors recommend additional guidance, but note slow progress in the development of embryo research policy.
Kirstin R.W. Matthews, Daniel Moralí June 28, 2022
Embryo
Emerging Human Embryo Research Technologies, the 14-day Rule, and the Special Status of the Embryo
The authors examine a proposal for new human embryo and embryoid guidelines, writing that before conducting any research beyond day 14, scientists must develop clear, thoughtful and culturally sensitive guidelines that include limitations and oversight procedures to ensure that science responds to societal needs and values.
Kirstin R.W. Matthews, Ana S. Iltis, Sam Lowe December 21, 2021
Stethoscope on top of chart
Private Equity Investments In Health Care: An Overview Of Hospital And Health System Leveraged Buyouts, 2003–17
Private equity investment in hospitals has grown substantially in the 21st century, and it accelerated in the years leading up the COVID-19 pandemic. In this study of short-term acute care hospitals acquired by private equity firms, the authors find they not only have higher markups and profit margins, they’re also slower to expand their staffs.
Anaeze C. Offodile II, Vivian Ho May 4, 2021